Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer

Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer

Systemic characterization of genomic alterations into signaling pathways helps to understand the molecular pathogenies of colorectal cancer; however, their clinical implications remain unclear. Here, 128 patients with metastatic colorectal cancer (mCRC) receiving targeted next generation sequencing...

Full description

Bibliographic Details
Main Authors:	Yi-Hsuan Huang, Peng-Chan Lin, Wu-Chou Su, Ren-Hao Chan, Po-Chuan Chen, Bo-Wen Lin, Meng-Ru Shen, Shang-Hung Chen, Yu-Min Yeh
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Diagnostics
Subjects:	metastatic colorectal cancer next-generation sequencing genomic profiling oncogenic signaling pathways
Online Access:	https://www.mdpi.com/2075-4418/11/12/2308

Similar Items

Comparison of Next-Generation Sequencing and Polymerase Chain Reaction for Personalized Treatment-Related Genomic Status in Patients with Metastatic Colorectal Cancer
by: Wei-Chih Su, et al.
Published: (2022-04-01)

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
by: Silvio Ken Garattini, et al.
Published: (2021-07-01)

Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol
by: Shang-Hung Chen, et al.
Published: (2019-06-01)

Oncogenic Functions and Clinical Significance of Circular RNAs in Colorectal Cancer
by: Maria Radanova, et al.
Published: (2021-07-01)

PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients
by: Hung-Chih Hsu, et al.
Published: (2018-09-01)

Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
by: Yakup Ergun, et al.
Published: (2020-01-01)

KRAS, NRAS, and BRAF Mutation Pattern in Metastatic Colorectal Cancer: A Study from Northwest Iran
by: Roya Dolatkhah, et al.
Published: (2019-08-01)

Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer
by: Karel C. Smit, et al.
Published: (2022-02-01)

ZBTB7A functioned as an oncogene in colorectal cancer
by: Li Wang, et al.
Published: (2020-11-01)

CLINICAL EXPERIENCE OF COMBINED AVASTIN THERAPY IN METASTATIC COLORECTAL CANCER
by: V. A. Ekimov
Published: (2015-02-01)

Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancer
by: Yi-Hsin Liang, et al.
Published: (2022-10-01)

Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis
by: Bradley Ashley Gue Ong, et al.
Published: (2022-04-01)

Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer
by: Ning Jia, et al.
Published: (2021-07-01)

Expert consensus on maintenance treatment for metastatic colorectal cancer in China
by: Rui-Hua Xu, et al.
Published: (2016-01-01)

High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer
by: Seung Eun Lee, et al.
Published: (2021-05-01)

Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities
by: Carina Neitzel, et al.
Published: (2020-06-01)

SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients
by: Zhu Mei, et al.
Published: (2018-04-01)

CLINICAL EXPERIENCE OF PROLONGED AVASTIN THERAPY IN METASTATIC COLORECTAL CANCER
by: A. F. Saidullaeva
Published: (2015-02-01)

CLINICAL EXPERIENCE OF PROLONGED BEVACIZUMAB THERAPY IN METASTATIC COLORECTAL CANCER
by: I. S. Bulavina, et al.
Published: (2015-02-01)

Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer
by: O I Kit, et al.
Published: (2017-06-01)

Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis
by: Chen D, et al.
Published: (2018-08-01)

The role of regorafenib in the treatment of metastatic colorectal cancer
by: A A Tryakin
Published: (2016-06-01)

Oncogenic Genetic Alterations in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China
by: Ma Y, et al.
Published: (2020-10-01)

OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01)

Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
by: Alessandro Ottaiano, et al.
Published: (2022-01-01)

Oncogenes /
by: 311669 Cooper, Geoffrey M.
Published: (1995)

CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin
by: Jingjing Xu, et al.
Published: (2018-06-01)

SHORT-TERM RESULTS OF SIMULTANEOUS SURGERIES AT METASTATIC COLORECTAL CANCER
by: A. S. Zagaynov, et al.
Published: (2017-02-01)

The Effect Of Chemotherapy On Malnutrition In Geriatric Group With Metastatic Colorectal Cancer
by: Esat Namal
Published: (2019-01-01)

Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer
by: Sarah C. Markt, et al.
Published: (2023-01-01)

Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
by: Roya Dolatkhah, et al.
Published: (2021-01-01)

Oncogene proteins.
by: Malloy, Artur H., et al.
Published: (c200)

Oncogenic fusion transcript analysis identified ADAP1‐NOC4L, potentially associated with metastatic colorectal cancer
by: Amin Talebi, et al.
Published: (2023-01-01)

Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance
by: Yeh YM, et al.
Published: (2019-08-01)

Mutational Status of <i>SMAD4</i> and <i>FBXW7</i> Affects Clinical Outcome in <i>TP53</i>–Mutated Metastatic Colorectal Cancer
by: Sara Lahoz, et al.
Published: (2022-11-01)

Cetuximab in first line treatment of metastatic colorectal cancer
by: Carlo Barone, et al.
Published: (2012-07-01)

<i>TP53</i> DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer
by: Hung-Chih Hsu, et al.
Published: (2019-07-01)

Kras in metastatic colorectal cancer
by: A Wicki, et al.
Published: (2010-11-01)

BRAF mutation in colorectal cancer: An update
by: Colombo Alfredo, et al.
Published: (2023-01-01)

Comparison of Carcinoembryonic Antigen Level and E-Cadherin Expression between Metastatic and Non-Metastatic Colorectal Carcinoma in RSUP, Dr. Sardjito Yogyakarta-Indonesia
by: Rianto Prabowo, et al.
Published: (2023-10-01)